Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Canarypox virus expressing wild type p53 for gene therapy in murine tumors mutated in p53.

Cancer gene therapy - 1 Feb 2001

Odin L, Favrot M, Poujol D, Michot J P, Moingeon P, Tartaglia J, Puisieux I

Abstract excerpt

The antitumor activity of a recombinant canarypox virus expressing wild type murine p53 (ALVAC-p53) was investigated in two murine syngeneic tumors harboring an endogenous p53 mutation (CMS4 and TS/A). Direct intratumor injections of ALVAC-p53 in CMS4 pre-established subcutaneous tumors induced t...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Antibodies, Neoplasm
Share to Gene Transfer Techniques
Share to Genetic Therapy

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Injections, Subcutaneous

Share to Mice, Nude

Share to Spleen

Share to T-Lymphocytes, Cytotoxic

Source

Identifiers

PMID: 11263530
DOI: 10.1038/sj.cgt.7700279

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 2 Sept 2026. Prepared record publication-11263530-2026-09-02.1. Manifest publication-graph-cohort-2026-09-02.1.

Source receipt: PubMed via Helena Literature Corpus, retrieved 2 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Canarypox virus expressing wild type p53 for gene therapy in murine tumors mutated in p53.PMID 11263530Read ↗

p53 as a target for cancer vaccines: recombinant canarypox virus vectors expressing p53 protect mice against lethal tumor cell challenge.Semantic proximity Read ↗

Antitumor effect of intratumoral administration of bone marrow-derived dendritic cells transduced with wild-type p53 gene.Semantic proximity Read ↗

DNA vaccination with a mutated p53 allele induces specific cytolytic T cells and protects against tumor cell growth and the formation of metastasis.Semantic proximity Read ↗

Combining Oncolytic Virotherapy with p53 Tumor Suppressor Gene TherapySemantic proximity Read ↗

Adenovirus p53 gene therapySemantic proximity Read ↗

New p53-based anti-cancer therapeutic strategies.Semantic proximity Read ↗

Mitochondrially targeted wild-type p53 induces apoptosis in a solid human tumor xenograft modelSemantic proximity Read ↗

Combination of p53 cancer vaccine with chemotherapy in patients with extensive stage small cell lung cancer.Semantic proximity Read ↗

Clinical utility of recombinant adenoviral human p53 gene therapy: current perspectivesSemantic proximity Read ↗

Oncolytic Activity of Vesicular Stomatitis Virus Is Effective against Tumors Exhibiting Aberrant p53, Ras, or Myc Function and Involves the Induction of ApoptosisSemantic proximity Read ↗

A retroviral wild-type p53 expression vector penetrates human lung cancer spheroids and inhibits growth by inducing apoptosisSemantic proximity Read ↗

Suppression of tumor growth using a recombinant adenoviral vector carrying the dominant-negative mutant gene Survivin-D53A in a nude mice model.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.